BioChain’s Life Sciences Real Estate Investment Strategy is Focused Exclusively on the Development of Laboratory, Good Manufacturing Process (cGMP), and R&D space.

We are operating in the highly-coveted markets of Boston, San Francisco and North San Diego, with offices and teams in Boston and Los Angeles.

Strong proximal locations to existing Life Sciences clusters and highly-skilled workforces.

Actively seeking land for entitlement and development, while also targeting existing industrial buildings, office buildings or retail for redevelopment into lab/R&D or Bio-manufacturing.